As panic and geopolitics drive drug and bordering policy, harm reduction advocates find new ground at the UN — mobilising evidence, resisting disinformation, and taking the fight for rights to a global stage.
Indonesia’s drug policy is under review as civil society pushes for health- and rights-based reforms, including legal changes, better treatment access, gender-sensitive harm reduction, and respectful kratom regulation rooted in indigenous knowledge.
In a historic move, the UN CRPD urges Canada to support safe supply and voluntary, rights-based harm reduction. Advocates from the HIV Legal Network call on the government to act, reform drug policy, and uphold disability rights.
Ghada Waly’s resignation offers the UN Secretary-General a chance to appoint a leader who will align UNODC with human rights-based drug policies and the broader UN system.
The INCB’s 2024 report highlights the global failure to ensure equitable access to controlled medicines for pain relief, palliative care, and harm reduction — urging urgent, rights-affirming reforms.
Against a backdrop of global turmoil and multilateral rupture, the 68th session of the CND marked a turning point in the history of global drug policy by deciding to create a panel of independent experts to rethink the global drug control regime.
IDPC marks Human Rights Day 2024 by shining a light on setbacks, key progress and promising avenues to better align drug policies and human rights standards.
The resolution's veneer of consensus betrays deepening fractures in global drug policy debates, as demonstrated by the string of 'disassociation' statements that followed the document's adoption.
Co-founder of IDPC, renowned scholar and beloved colleague and family man, Dave departed on 20 November 2024 after a long and valiant battle with cancer.
